Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Pflugers Arch. 2018 Nov 13;471(3):441–453. doi: 10.1007/s00424-018-2227-8

Fig. 1.

Fig. 1

Treatment of animals with a mitochondrial-targeted antioxidant (SS-31) protects the (A) diaphragm and limb muscles (i.e., (B) plantaris and (C) soleus) of rodents against DOX-induced muscle fiber atrophy. See the text for more details. Data are from Min et al. [59]. Key: CON = control; DOX = doxorubicin treatment; CON + SS31= control animals treated with SS31; DOX + SS31= animals treated with both DOX and SS31; * = different (P<0.05) from all other groups; # = different (P<0.05) from all CON and CON+SS31; † = different (P<0.05) from CON.